Log In
BCIQ
Print this Print this
 

High-dose Fluzone

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHigh-dose preservative-free influenza vaccine against influenza (H1N1, H3N2 and B) viral strains
Molecular Target Influenza antigen
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza virus in adults 65 years of age and older
Regulatory Designation U.S. - Accelerated Approval (Vaccinate against influenza virus in adults 65 years of age and older)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today